Rep. James Comer (R-KY) (Graeme Sloan/Sipa USA/Sipa via AP Images)
March 2, 2023 03:45 PM EST
Pharma

House over­sight chair calls for in­ves­ti­ga­tion in­to PBM­s' tac­tics to in­crease drug costs

Katherine Lewin

News Reporter

In an­oth­er ef­fort to in­ves­ti­gate phar­ma mid­dle­men and their im­pact on health­care costs, House Over­sight Com­mit­tee Chair James Com­er (R-KY) is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times